$ALGN
ALIGN TECHNOLOGY INC Stock $algn

$algn Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000109714913000033 Filed on August 02, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$163.8M	$145.6M
YoY Change	12.5%	21.27%
Cost Of Revenue	$40.14M	$36.83M
YoY Change	8.99%	27.21%
Gross Profit	$123.7M	$108.8M
YoY Change	13.69%	19.38%
Gross Profit Margin	75.5%	74.71%
Selling, General & Admin	$74.87M	$62.11M
YoY Change	20.55%	-3.98%
% of Gross Profit	60.53%	57.08%
Research & Development	$10.92M	$10.68M
YoY Change	2.21%	15.21%
% of Gross Profit	8.83%	9.82%
Depreciation & Amortization	$3.800M	$4.200M
YoY Change	-9.52%	-8.7%
% of Gross Profit	3.07%	3.86%
Operating Expenses	$85.79M	$72.79M
YoY Change	17.86%	-2.35%
Operating Profit	$37.90M	$36.01M
YoY Change	5.25%	117.01%
Interest Expense	-$300.0K	$500.0K
YoY Change	-160.0%	400.0%
% of Operating Profit	-0.79%	1.39%
Other Income/Expense, Net	-$335.0K	$541.0K
YoY Change	-161.92%	-276.8%
Pretax Income	$37.57M	$36.55M
YoY Change	2.77%	124.4%
Income Tax	$8.246M	$8.061M
% Of Pretax Income	21.95%	22.05%
Net Earnings	$29.32M	$28.49M
YoY Change	2.91%	155.26%
Net Earnings / Revenue	17.9%	19.57%
Basic Earnings Per Share	$0.36	$0.35
Diluted Earnings Per Share	$0.36	$0.34
COMMON SHARES
Basic Shares Outstanding	80.58M shares	80.38M shares
Diluted Shares Outstanding	82.15M shares	82.95M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$278.4M	$283.6M
YoY Change	-1.81%	61.66%
Cash & Equivalents	$164.5M	$262.8M
Short-Term Investments	$113.9M	$20.75M
Other Short-Term Assets	$35.60M	$34.80M
YoY Change	2.3%	52.63%
Inventory	$15.70M	$14.62M
Prepaid Expenses
Receivables	$112.4M	$102.1M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$442.1M	$435.1M
YoY Change	1.6%	51.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$76.93M	$72.21M
YoY Change	6.54%	94.63%
Goodwill	$61.71M	$135.8M
YoY Change	-54.56%	0.35%
Intangibles	$24.98M	$47.90M
YoY Change	-47.86%
Long-Term Investments	$62.90M	$20.50M
YoY Change	206.83%	400.0%
Other Assets	$4.674M	$2.765M
YoY Change	69.04%	-91.19%
Total Long-Term Assets	$261.8M	$309.0M
YoY Change	-15.28%	16.25%
TOTAL ASSETS
Total Short-Term Assets	$442.1M	$435.1M
Total Long-Term Assets	$261.8M	$309.0M
Total Assets	$703.9M	$744.2M
YoY Change	-5.41%	34.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.56M	$15.23M
YoY Change	41.57%	46.4%
Accrued Expenses	$75.78M	$69.21M
YoY Change	9.49%	24.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$160.7M	$143.8M
YoY Change	11.69%	31.36%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$23.04M	$14.03M
YoY Change	64.21%	79.9%
Total Long-Term Liabilities	$23.04M	$14.03M
YoY Change	64.21%	79.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$160.7M	$143.8M
Total Long-Term Liabilities	$23.04M	$14.03M
Total Liabilities	$183.7M	$157.9M
YoY Change	16.36%	34.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$172.9M	-$68.68M
YoY Change	151.7%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$520.2M	$586.3M
YoY Change
Total Liabilities & Shareholders Equity	$703.9M	$744.2M
YoY Change	-5.41%	36.04%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$29.32M	$28.49M
YoY Change	2.91%	155.26%
Depreciation, Depletion And Amortization	$3.800M	$4.200M
YoY Change	-9.52%	-8.7%
Cash From Operating Activities	$53.30M	$35.40M
YoY Change	50.56%	19.19%
INVESTING ACTIVITIES
Capital Expenditures	-$3.800M	-$13.20M
YoY Change	-71.21%	131.58%
Acquisitions
YoY Change
Other Investing Activities	-$136.6M	-$5.700M
YoY Change	2296.49%	-96.75%
Cash From Investing Activities	-$140.4M	-$18.90M
YoY Change	642.86%	-89.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-77.30M	22.00M
YoY Change	-451.36%	92.98%
NET CHANGE
Cash From Operating Activities	53.30M	35.40M
Cash From Investing Activities	-140.4M	-18.90M
Cash From Financing Activities	-77.30M	22.00M
Net Change In Cash	-164.4M	38.50M
YoY Change	-527.01%	-127.52%
FREE CASH FLOW
Cash From Operating Activities	$53.30M	$35.40M
Capital Expenditures	-$3.800M	-$13.20M
Free Cash Flow	$57.10M	$48.60M
YoY Change	17.49%	37.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	21556000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19549000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98992000	USD
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	112367000	USD
CY2013Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1444000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	572000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	74247000	USD
CY2013Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75776000	USD
CY2012Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8333000	USD
CY2013Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	9547000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2349000	USD
CY2013Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1160000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-44000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	203000	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	693102000	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	670732000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7265000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13675000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10142000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5279000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1702000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2246000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	26320000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2013Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2012Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5221000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	234000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1970000	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	26300000	USD
CY2013Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	26300000	USD
CY2013Q2	us-gaap	Assets Assets	703894000	USD
CY2012Q4	us-gaap	Assets Assets	756312000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	485793000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	442093000	USD
CY2013Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	176818000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	49737000	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28485000	USD
CY2013Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	113933000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	113933000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	28485000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	21252000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	62885000	USD
CY2012Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	21252000	USD
CY2013Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	62885000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	306386000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	164497000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	262799000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240675000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22124000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-141889000	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79699000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80611000	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79699000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80611000	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	8000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	49090000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27959000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12910000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29126000	USD
CY2012Q2	us-gaap	Cost Of Revenue CostOfRevenue	36826000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	71145000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	80868000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	40137000	USD
CY2012Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	237000	USD
CY2013Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent	2054000	USD
CY2013Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate DebtInstrumentBasisSpreadOnVariableRate	0.0175
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9228000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6272000	USD
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	63322000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	61975000	USD
CY2013Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	30622000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21609000	USD
CY2013Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	30300000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5905000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7087000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.62
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.36
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	53000	USD
CY2013Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.224
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-7.459
CY2012Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.221
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39577000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	16745000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39621000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	15331000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	15331000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	16745000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1325000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2629000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2629000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2629000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2635000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53485000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53325000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24976000	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23021000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57375000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27027000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46532000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	99236000	USD
CY2013Q2	us-gaap	Goodwill Goodwill	61713000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	3509000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40693000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2012Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40700000	USD
	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	-339000	USD
	us-gaap	Gross Profit GrossProfit	209560000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	123691000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	108800000	USD
	us-gaap	Gross Profit GrossProfit	236540000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	37566000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36553000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	63747000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1497000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8061000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8246000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14271000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11166000	USD
CY2013Q1	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	500000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1954000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	50000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11813000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7567000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3298000	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-3927000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2099000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7004000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	581000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-2848000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1053000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45777000	USD
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24975000	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3604000	USD
CY2013Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5345000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	15122000	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	15704000	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	7629000	USD
CY2013Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6464000	USD
CY2013Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3895000	USD
CY2012Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3889000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	174995000	USD
CY2013Q2	us-gaap	Liabilities Liabilities	183696000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	756312000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	703894000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	160654000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155771000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-61896000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36283000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-143772000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56910000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	42755000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	63726000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	28492000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12663000	USD
	us-gaap	Net Income Loss NetIncomeLoss	49476000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	29320000	USD
CY2013Q2	us-gaap	Noncurrent Assets NoncurrentAssets	76932000	USD
CY2012Q4	us-gaap	Noncurrent Assets NoncurrentAssets	79191000	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	541000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1323000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-271000	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-335000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
	us-gaap	Operating Expenses OperatingExpenses	236714000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	85790000	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	72788000	USD
	us-gaap	Operating Expenses OperatingExpenses	145542000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	36012000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-174000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	64018000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	37901000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	23942000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2367000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4921000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5500000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7184000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	52000	USD
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5517000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6878000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4674000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3454000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-25000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-12000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-183000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-186000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-521000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-361000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-64000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-194000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-247000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-386000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-533000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23042000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19224000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	13000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-74000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	125000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	138000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	95108000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2524000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1627000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3234000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	150806000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	43857000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7652000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25778000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9389000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35233000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35076000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	21128000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23689000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-13000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	18117000	USD
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	10002000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	5043000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	76932000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79191000	USD
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10680000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10916000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21206000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22198000	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	516000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1575000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89626000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-172868000	USD
CY2013Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4672000	USD
CY2012Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5253000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	317408000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	163828000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	280705000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	145626000	USD
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	47847000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	77804000	USD
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	39087000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	90128000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	13675000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10142000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1731000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.95
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	72000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	43561000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2023000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3276000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.51
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	43561000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2023000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	15.51
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	38241000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y9M22D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M13D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y10M13D
CY2013Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4453000	USD
CY2012Q2	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3513000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4050000	USD
CY2011Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3177000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	4050000	USD
CY2013Q2	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	4453000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	2381000	USD
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1777000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2113000	USD
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2784000	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1181000	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2700000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	95100000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	581317000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	520198000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	24000000	USD
CY2013Q2	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1900000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;text-indent:16px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with generally accepted accounting principles ("GAAP") in the United States of America (“U.S.”) requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, long-lived assets and goodwill, useful lives of intangible assets and property and equipment, stock-based compensation, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>
CY2013Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1573000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2570000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2636000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82954000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82446000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80909000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82149000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80576000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80909000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79810000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80384000	shares
CY2013Q2	algn	Accrued Accounts Payable AccruedAccountsPayable	3981000	USD
CY2012Q4	algn	Accrued Accounts Payable AccruedAccountsPayable	2866000	USD
CY2013Q2	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	3371000	USD
CY2012Q4	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	4088000	USD
CY2012Q4	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	2484000	USD
CY2013Q2	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	1101000	USD
CY2013Q2	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	9251000	USD
CY2012Q4	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	7548000	USD
CY2013Q2	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2012Q4	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	-45777000	USD
CY2013Q2	algn	Future Amortization Expense Thereafter FutureAmortizationExpenseThereafter	13129000	USD
	algn	Income Tax Expense Benefit Deductible Impairment Losses Amount IncomeTaxExpenseBenefitDeductibleImpairmentLossesAmount	4000000	USD
	algn	Income Tax Expense Benefit Impairment Losses Amount IncomeTaxExpenseBenefitImpairmentLossesAmount	5800000	USD
	algn	Income Tax Expense Benefit Nondeductible Expense Impairment Losses Amount IncomeTaxExpenseBenefitNondeductibleExpenseImpairmentLossesAmount	9700000	USD
	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P10M
CY2012	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P10M
CY2012	algn	Maturity Period Used To Classify Investments MaturityPeriodUsedToClassifyInvestments	P2Y
CY2013Q2	algn	Operating Leases Future Minimum Payments Due Remainder Of Period OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod	3918000	USD
	algn	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	310000	USD
	algn	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	-1081000	USD
	algn	Share Repurchases Price Paid Per Share ShareRepurchasesPricePaidPerShare	34.95
	algn	Standard Product Warranty Time Period StandardProductWarrantyTimePeriod	P1Y
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001097149
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	79837318	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ALIGN TECHNOLOGY INC
	dei	Trading Symbol TradingSymbol	ALGN

Files In Submission

Name	View Source	Status
0001097149-13-000033-index-headers.html	Edgar Link	pending
0001097149-13-000033-index.html	Edgar Link	pending
0001097149-13-000033.txt	Edgar Link	pending
0001097149-13-000033-xbrl.zip	Edgar Link	pending
algn-20130630.xml	Edgar Link	completed
algn-20130630.xsd	Edgar Link	pending
algn-20130630_cal.xml	Edgar Link	unprocessable
algn-20130630_def.xml	Edgar Link	unprocessable
algn-20130630_lab.xml	Edgar Link	unprocessable
algn-20130630_pre.xml	Edgar Link	unprocessable
algn-2013331xex311.htm	Edgar Link	pending
algn-2013331xex312.htm	Edgar Link	pending
algn-2013331xex321.htm	Edgar Link	pending
algn-2013630xq2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
q213utilizationgraph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALGN
ALIGN TECHNOLOGY INC Stock $algn

2013 Q2 Form 10-Q Financial Statement

#000109714913000033 Filed on August 02, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN ALIGN TECHNOLOGY INC Stock $algn

2013 Q2 Form 10-Q Financial Statement

#000109714913000033 Filed on August 02, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN
ALIGN TECHNOLOGY INC Stock $algn